Truist Securities analyst Richard Newitter maintains Treace Medical Concepts (NASDAQ:TMCI) with a

Treace Medical Concepts, Inc. (TMCI) Q2 2026 Earnings Call Transcript

Treace Medical Concepts NASDAQ: TMCI reported second-quarter 2026 revenue of $45.4 million, down 4%

Treace Medical Concepts (TMCI) came out with a quarterly loss of $0.24 per share versus the Zacks Co

Treace Medical Concepts (NASDAQ:TMCI) reported quarterly losses of $(0.24) per share which beat the

Treace Medical Concepts (NASDAQ:TMCI) raises FY2026 sales outlook from $202.000 million-$212.000 mil

PONTE VEDRA, Fla., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or ob

PONTE VEDRA, Fla., July 24, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the

Truist Securities analyst Richard Newitter maintains Treace Medical Concepts (NASDAQ:TMCI) with a

SAN DIEGO, July 13, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims

HyperPlate™ fixation technology further advances the SpeedPlate® implant platform by incorporating F

New portfolio addition to drive further penetration into incremental procedures throughout the foot

PONTE VEDRA, Fla., June 11, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the

SAN DIEGO, May 12, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims o

Treace Medical Concepts NASDAQ: TMCI reaffirmed its full-year 2026 revenue outlook after reporting a

Treace Medical Concepts, Inc. (TMCI) Q1 2026 Earnings Call Transcript

Treace Medical Concepts (TMCI) came out with a quarterly loss of $0.28 per share versus the Zacks Co

Treace Medical Concepts (NASDAQ:TMCI) raises FY2026 sales outlook from $200.000 million-$212.000 mil

Treace Medical Concepts (NASDAQ:TMCI) reported quarterly losses of $(0.28) per share which beat the

PONTE VEDRA, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "

PONTE VEDRA, Fla., April 24, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the

US stocks mixed; Dow falls 0.29% as inflation rate surges to 3.3%. Materials up 0.8%, financials dow

New portfolio addition taps into incremental procedures throughout the foot and ankle; strengthens T

PAVmed (NASDAQ: PAVM - Get Free Report) and Treace Medical Concepts (NASDAQ: TMCI - Get Free Report)

Lake Street analyst Ben Haynor maintains Treace Medical Concepts (NASDAQ:TMCI) with a Buy and low

Treace Medical Concepts (NASDAQ: TMCI) management told investors it is entering what it called a "tr

Treace Medical Concepts, Inc. (TMCI) Q4 2025 Earnings Call Transcript

2026 Financial OutlookThe Company is initiating full-year 2026 revenue guidance of $200 million to $

Treace Medical Concepts (NASDAQ:TMCI) reported quarterly losses of $(0.15) per share which met the a

PONTE VEDRA, Fla., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the

Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medica

Stifel analyst Rick Wise maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and lowers t

Truist Securities analyst Richard Newitter maintains Treace Medical Concepts (NASDAQ:TMCI) with a

Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI), a medical t

Truist Securities analyst Richard Newitter reiterates Treace Medical Concepts (NASDAQ:TMCI) with

UBS analyst Danielle Antalffy maintains Treace Medical Concepts (NASDAQ:TMCI) with a Neutral and

JP Morgan analyst Lilia-Celine Lozada downgrades Treace Medical Concepts (NASDAQ:TMCI) from Neutr

Treace Medical Concepts (NASDAQ:TMCI) lowers FY2025 sales outlook from $224.000 million-$230.000 mil

Treace Medical Concepts (NASDAQ:TMCI) reported quarterly losses of $(0.26) per share which beat the